When Judge Rodgers confirmed that Pfizer and plaintiffs’ leadership had reached a global settlement in principle, thousands of women asked the same question: what do I get, and when? The honest answer is that terms are not public. But global pharmaceutical settlements follow recognizable patterns, and the judge who is overseeing this one built the largest of them.
The typical structure
A master settlement agreement. Pfizer commits a total amount, or a formula, in exchange for releases from participating claimants. It usually requires a high participation rate to take effect.
Eligibility criteria. Minimum duration of use, a confirmed diagnosis, and a filing or registration cutoff. Claims outside the criteria are not covered.
An allocation matrix. Base amounts by injury tier — commonly surgery, radiation, and surveillance — adjusted for factors such as duration of use, age, complications, and permanent deficits.
A claims administrator and special master. Independent parties review documentation, assign points or tiers, and resolve disputes.
In the 3M earplug litigation, Judge Rodgers's court managed a $6 billion program for roughly 260,000 claims. The Depo-Provera docket is smaller and the injuries more uniform, which typically means a faster process.
Direct2Attorney · Litigation ContextThe decisions each claimant faces
Participate
Most claimants- Submit documentation to the administrator
- Receive a tier assignment and offer
- Accept and release, or appeal the assignment
- Payment on a program schedule
Opt out
Uncommon; case-specific- Continue litigating individually
- Possible trial, with its risks and delays
- Typically chosen for exceptionally severe injuries
- Requires firm's assessment and agreement
What determines your tier
Treatment is the primary driver. A craniotomy with lasting deficits sits at the top; a monitored tumor with no intervention sits lower. Duration of use, age at diagnosis, multiple tumors, recurrence, and complications adjust within tiers. Documentation quality affects how accurately the administrator places you, which is why records collection continues after the settlement announcement, not before it.
What to expect on timing
Final documents in comparable programs have taken three to nine months after an agreement in principle. Claims processing follows over a year or more. Late-filed claims are sometimes accommodated at reduced values or excluded entirely — the reason unfiled claimants should act now.
What this means if you're considering a claim
A settlement in principle rewards claimants who are in the system with complete documentation. If you used Depo-Provera for a year or more and have a meningioma diagnosis, a free review can determine eligibility and connect you with a participating firm that will handle the program process.
Want to understand where you'd fall?
Free, confidential review by a participating firm.
Common Questions
No. Any figures online are projections. Terms are confidential until documents are finalized.
Contingency fees are typically deducted from the recovery; common benefit fees may also apply in MDLs. Confirm terms with the firm in writing.
Releases typically cover future claims. Some programs include provisions for recurrence; a firm can explain.
Possibly, depending on the terms. Filing before finalization is the safer course.
No. Direct2Attorney’s review is free, and participating law firms typically work on contingency, meaning fees are generally paid only if there is a recovery. Confirm fee terms in writing with the firm.
